I like the chances for a big move next week.....
RVX (or RVXCF) is so tightly held that those selling short, they've been failing to deliver the shares they're selling...Naked Short Selling in other words. Thankfully the TSX has their "Buy In" facility that locates shares, forcing short sellers to cover off at about a 10% premium....there were 12,000 such shares bought for $2.39 on Friday.
That tells me that liquidity is almost non-existent, so if any substantial buying moves in I like the chances for a big move up next week, maybe even north of $3 CDN on the TSX. $3 CDN would about $2.25 in USD.
Last week we saw Resverlogix get written up on Seeking Alpha by some group called Avisol Capital which has over 7,000 followers on that site. Now Friday we have this Motley Fool write up.
On top of that Friday will be the last trading day of the week, of June and of the second quarter.
Here's hoping we get the 7th update from the DSMB and that its another thumbs up with no safety or efficacy concerns noted again with a recommendation for the trial to continue with no modifications needed.
Looking forward to the trading.
RVX (or RVXCF) is so tightly held that those selling short, they've been failing to deliver the shares they're selling...Naked Short Selling in other words. Thankfully the TSX has their "Buy In" facility that locates shares, forcing short sellers to cover off at about a 10% premium....there were 12,000 such shares bought for $2.39 on Friday.
That tells me that liquidity is almost non-existent, so if any substantial buying moves in I like the chances for a big move up next week, maybe even north of $3 CDN on the TSX. $3 CDN would about $2.25 in USD.
Last week we saw Resverlogix get written up on Seeking Alpha by some group called Avisol Capital which has over 7,000 followers on that site. Now Friday we have this Motley Fool write up.
On top of that Friday will be the last trading day of the week, of June and of the second quarter.
Here's hoping we get the 7th update from the DSMB and that its another thumbs up with no safety or efficacy concerns noted again with a recommendation for the trial to continue with no modifications needed.
Looking forward to the trading.
If you want to taste the fruit, you have to go out on a limb. But if you wait for the herd to move out on the limb....the branch tends to snap.
Recent RVXCF News
- Resverlogix Corp. Announces Filing of Annual Filings and Revocation of MCTO • Newsfile • 04/16/2026 11:15:00 AM
- Resverlogix Corp. Announces Issuance of MCTO by ASC • Newsfile • 04/02/2026 11:15:00 AM
- Resverlogix Corp. Provides Bi-Weekly MCTO Status Update • Newsfile • 03/31/2026 11:09:00 PM
- Resverlogix Announces Delay in Filing of Annual Financial Statements, AIF, and MD&A • Newsfile • 03/18/2026 02:49:00 AM
- Resverlogix Appoints Bradley Glass to Board of Directors • Newsfile • 11/18/2025 10:15:00 PM
